West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 99,700 | 43,600 | 150,700 | 150,700 | 99,700 |
| Depreciation Amortization | 51,900 | 26,400 | 96,700 | 71,800 | 46,800 |
| Income taxes - deferred | N/A | N/A | 41,700 | N/A | N/A |
| Accounts receivable | N/A | N/A | -39,700 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 12,600 | N/A | N/A |
| Other Working Capital | -33,900 | -28,300 | -41,400 | -65,400 | -60,600 |
| Other Operating Activity | 9,300 | 3,300 | 42,700 | 24,700 | 20,100 |
| Operating Cash Flow | $127,000 | $45,000 | $263,300 | $181,800 | $106,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48,200 | -28,000 | -130,800 | -101,300 | -67,000 |
| Net Acquisitions | N/A | N/A | -6,000 | -6,000 | -6,000 |
| Other Investing Activity | 2,500 | -700 | 3,200 | 3,100 | 2,800 |
| Investing Cash Flow | $-45,700 | $-28,700 | $-133,600 | $-104,200 | $-70,200 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | -34,900 | -1,800 | -1,200 |
| Common Stock Issued | 8,900 | 1,400 | 40,100 | 39,200 | 31,700 |
| Common Stock Repurchased | -70,800 | -47,900 | -74,400 | -30,700 | -30,700 |
| Dividend Paid | -20,700 | -10,400 | -39,100 | -28,700 | -19,100 |
| Other Financing Activity | 0 | 0 | -700 | -500 | -200 |
| Financing Cash Flow | $-82,600 | $-56,900 | $-109,000 | $-22,500 | $-19,500 |
| Exchange Rate Effect | -9,100 | 4,500 | 12,200 | 11,200 | 7,300 |
| Beginning Cash Position | 235,900 | 235,900 | 203,000 | 203,000 | 203,000 |
| End Cash Position | 225,500 | 199,800 | 235,900 | 269,300 | 226,600 |
| Net Cash Flow | $-10,400 | $-36,100 | $32,900 | $66,300 | $23,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 127,000 | 45,000 | 263,300 | 181,800 | 106,000 |
| Capital Expenditure | -48,200 | -28,000 | -130,800 | -101,300 | -67,000 |
| Free Cash Flow | 78,800 | 17,000 | 132,500 | 80,500 | 39,000 |